Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)
Clinical trial NCT03297294 · TERMINATED
Trial details
- NCT number
- NCT03297294
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-14
- Primary completion
- 2019-03-25
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.